<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522"><gtr:id>4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522</gtr:id><gtr:name>UNLISTED</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C5A9884D-F4F2-4A19-9E24-1268191D0E05"><gtr:id>C5A9884D-F4F2-4A19-9E24-1268191D0E05</gtr:id><gtr:name>University of Siena</gtr:name><gtr:address><gtr:line1>Universita Delgi Studi Di Siena</gtr:line1><gtr:line2>Via Banchi di Sotto 55</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20FDE301-787F-433E-A102-D64CC1EF3508"><gtr:id>20FDE301-787F-433E-A102-D64CC1EF3508</gtr:id><gtr:name>University of Cagliari</gtr:name><gtr:address><gtr:line1>Piazza d'Armi - 09123</gtr:line1><gtr:line4>Cagliari</gtr:line4><gtr:postCode>09123</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2D017FB7-303D-48E6-AAFF-06303F046804"><gtr:id>2D017FB7-303D-48E6-AAFF-06303F046804</gtr:id><gtr:name>Royal Marsden NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C5A9884D-F4F2-4A19-9E24-1268191D0E05"><gtr:id>C5A9884D-F4F2-4A19-9E24-1268191D0E05</gtr:id><gtr:name>University of Siena</gtr:name><gtr:address><gtr:line1>Universita Delgi Studi Di Siena</gtr:line1><gtr:line2>Via Banchi di Sotto 55</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20FDE301-787F-433E-A102-D64CC1EF3508"><gtr:id>20FDE301-787F-433E-A102-D64CC1EF3508</gtr:id><gtr:name>University of Cagliari</gtr:name><gtr:address><gtr:line1>Piazza d'Armi - 09123</gtr:line1><gtr:line4>Cagliari</gtr:line4><gtr:postCode>09123</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2D017FB7-303D-48E6-AAFF-06303F046804"><gtr:id>2D017FB7-303D-48E6-AAFF-06303F046804</gtr:id><gtr:name>Royal Marsden NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522"><gtr:id>4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522</gtr:id><gtr:name>UNLISTED</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2BBB9333-DD0A-4B1B-9ACA-0EF49E1F9F6B"><gtr:id>2BBB9333-DD0A-4B1B-9ACA-0EF49E1F9F6B</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Scotton</gtr:surname><gtr:orcidId>0000-0002-9671-9057</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800340"><gtr:id>DDF8E2FD-9363-4E89-A5B9-F724BC12AD01</gtr:id><gtr:title>Crosstalk between extravascular coagulation, chemokine networks and immunity in fibroproliferative lung disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0800340</gtr:grantReference><gtr:abstractText>When the lungs are damaged by pollution, smoke, trauma or infection, the coagulation cascade system of blood clotting proteins (coagulation factors), is activated in order to temporarily plug damaged blood vessels. Aside from their roles in clotting, many of these coagulation factors can also directly affect lung repair mechanisms. In lung disease, this process can snowball - unwarranted activation of the coagulation cascade has been implicated in the excessive scarring known as fibrosis, which leads to the eventual loss of normal lung function in adults, children and premature infants. There are currently no effective therapies, so the insidious progression of fibrosis often results in death of affected individuals. New therapies are therefore urgently required. Encouragingly, the results of a recent clinical trial support the notion that anti-coagulant drugs may be beneficial. Our work has identified a particular coagulation factor which, unusually, is made within the lung itself. This project will begin to identify the mechanisms by which this and other coagulation factors can lead to lung inflammation and scarring, using an experimental model of fibrosis, cultured cells and patient biopsy material. This information will help in the development of more specific and useful therapies for this devastating and fatal disease.</gtr:abstractText><gtr:technicalSummary>Introduction: Uncontrolled activation of the coagulation cascade contributes to the pathophysiology of several respiratory conditions, including pulmonary fibrosis. Current dogma assumes that coagulation zymogens are derived from the circulation and locally-activated in response to tissue injury. However, my recent data show for the first time that coagulation factor X (FX) gene expression is significantly upregulated in pulmonary fibrosis and that the bronchial/alveolar epithelium represents a prominent cellular source of FX - the activated form of which (FXa) exerts potent pro-inflammatory/pro-fibrotic effects. These findings herald a paradigm shift in our understanding of the tissue origin of excessive procoagulant signaling in lung disease, and are consistent with the existence of an inducible extravascular lung coagulation system. Our work has also highlighted the involvement of proteinase-activated receptor 1 (PAR1) as the major signaling receptor for coagulation proteinases in the injured lung. Hypothesis: Extravascular pro-coagulant activity, signaling via PAR1, influences innate immune mechanisms and chemokine production to drive the development of lung inflammation and fibrosis. Aims: My aims are to determine: a) the relative contribution of locally-produced and activated FX to experimental lung inflammation and fibrosis; b) the mechanisms mediating increased FX gene expression; c) how FXa (via its receptor, PAR1) contributes to the establishment of chemokine networks involved in recruitment of leukocytes and circulating mesenchymal progenitor cells to the injured lung; and d) the significance of extravascular pro-coagulant activity for monocyte/macrophage activation and formation of secondary lymphoid tissue. Methods: These studies will employ an integrated approach involving a well-established animal model of inflammation/fibrosis, in vitro biology and patient material. FX production/activity in vivo will be manipulated using shRNA or a specific FXa inhibitor. Immunohistochemistry, ELISA, flow cytometry and real-time RT-PCR will be used to elucidate effects on inflammation/fibrosis and chemokine networks. In vitro cell biology, including both mono- and co-culture experiments, will be used to investigate FX gene regulation, and determine cross-talk between epithelium and fibroblasts or macrophages. Patient biopsy material and bronchoalveolar lavage fluid will be used to underpin this basic science programme and ensure findings are of human disease relevance. Outcomes: Besides expanding our knowledge of the fundamental crosstalk between the coagulation cascade, inflammation and immunity, this work will provide novel insights into the pathophysiological mechanisms underlying lung inflammation and fibrosis. Interfering with FX production or signaling may represent an extremely attractive target for therapeutic intervention in lung injury and fibrosis, and potentially other lung diseases associated with excessive pro-coagulant activity.</gtr:technicalSummary><gtr:fund><gtr:end>2013-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>858367</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>2A2D4A42-AEBF-42D4-8AFB-38F22B914012</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-9</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cagliari</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Goblet cell metaplasia study</gtr:description><gtr:id>774CB922-3806-4902-ABCB-B6DCBB5227D8</gtr:id><gtr:impact>19307611</gtr:impact><gtr:outcomeId>0ADE80C4A1C-1</gtr:outcomeId><gtr:piContribution>Intellectual and technical input, plus provision of research facilities.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Mechanical Engineering</gtr:department><gtr:description>Generation of cell-scaffold composites using bio-engineering</gtr:description><gtr:id>8B09D94B-81BE-4708-9A82-FA9EA35E8E5D</gtr:id><gtr:impact>This work has resulted in two publications (PMID: 21755598 and 26508202).

This collaboration involves the life sciences, medicine and engineering.</gtr:impact><gtr:outcomeId>ZE4EghFMVpM-1</gtr:outcomeId><gtr:partnerContribution>One aim of my CDA was to investigate cell-cell interactions using a simple co-culture system. This collaboration enabled the use of cutting-edge bioengineering approaches to specifically seed cells within a three-dimensional protein scaffold. Refinement of this process should expedite my cell co-culture research, and could also have relevance for regenerative medicine.</gtr:partnerContribution><gtr:piContribution>I provided the cellular material and the biological expertise for characterising the cellular phenotype after creation of the cell-scaffold composites.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Marsden NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>6D5CD534-4E88-4F94-BDD6-F4C8F91C3306</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-4</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine (UCSF)</gtr:department><gtr:description>Consensus on Epithelial Cells in Idiopathic Pulmonary Fibrosis</gtr:description><gtr:id>E99BCD83-ED33-464F-B032-5B749B760254</gtr:id><gtr:impact>A consensus statement on the appropriate use of epithelial cells in Idiopathic Pulmonary Fibrosis research was presented at the International Colloquium on Lung Fibrosis in November 2010. The eventual aim of all the participants is to set up a UK-wide consortium for the sharing of knowledge and access to human lung samples.</gtr:impact><gtr:outcomeId>WfmTVTfMx5S-7</gtr:outcomeId><gtr:partnerContribution>Access to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertise</gtr:partnerContribution><gtr:piContribution>Sharing of expert knowledge, and eventually access to human tissue samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Social and Community Medicine</gtr:department><gtr:description>Consensus on Epithelial Cells in Idiopathic Pulmonary Fibrosis</gtr:description><gtr:id>6AC41FEC-1BBE-47C0-AFC8-B08CB7C2428B</gtr:id><gtr:impact>A consensus statement on the appropriate use of epithelial cells in Idiopathic Pulmonary Fibrosis research was presented at the International Colloquium on Lung Fibrosis in November 2010. The eventual aim of all the participants is to set up a UK-wide consortium for the sharing of knowledge and access to human lung samples.</gtr:impact><gtr:outcomeId>WfmTVTfMx5S-9</gtr:outcomeId><gtr:partnerContribution>Access to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertise</gtr:partnerContribution><gtr:piContribution>Sharing of expert knowledge, and eventually access to human tissue samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>472274EF-A88A-49A1-B98C-6A01CD04EC16</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-11</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>D479739A-4D25-45EF-88AD-FFF145E1C513</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-7</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Durham University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>DEC67012-1430-4493-9D44-EB67683049E2</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-3</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biomedical Sciences Nottingham</gtr:department><gtr:description>Consensus on Epithelial Cells in Idiopathic Pulmonary Fibrosis</gtr:description><gtr:id>8A8D2C79-4E5A-485C-B998-3ACC2F749120</gtr:id><gtr:impact>A consensus statement on the appropriate use of epithelial cells in Idiopathic Pulmonary Fibrosis research was presented at the International Colloquium on Lung Fibrosis in November 2010. The eventual aim of all the participants is to set up a UK-wide consortium for the sharing of knowledge and access to human lung samples.</gtr:impact><gtr:outcomeId>WfmTVTfMx5S-1</gtr:outcomeId><gtr:partnerContribution>Access to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertise</gtr:partnerContribution><gtr:piContribution>Sharing of expert knowledge, and eventually access to human tissue samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>0536FD23-2EDA-48E4-9C2E-F1B2E9E3091D</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-13</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>1B05DEC1-374D-4598-A1D1-D20C40DE449E</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-5</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection, Immunity and Cardiovascular Disease</gtr:department><gtr:description>Consensus on Epithelial Cells in Idiopathic Pulmonary Fibrosis</gtr:description><gtr:id>7D5C352D-78FA-47F1-8521-03FD75DC0A66</gtr:id><gtr:impact>A consensus statement on the appropriate use of epithelial cells in Idiopathic Pulmonary Fibrosis research was presented at the International Colloquium on Lung Fibrosis in November 2010. The eventual aim of all the participants is to set up a UK-wide consortium for the sharing of knowledge and access to human lung samples.</gtr:impact><gtr:outcomeId>WfmTVTfMx5S-5</gtr:outcomeId><gtr:partnerContribution>Access to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertise</gtr:partnerContribution><gtr:piContribution>Sharing of expert knowledge, and eventually access to human tissue samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>62126B20-9FFC-4DA0-ADF8-B2F91568B773</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-2</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>E6A8C4D2-A18C-4468-A483-D4F790A5389A</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-1</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>214A8ACD-A0DD-4A43-8B66-DEB69DE6D8BB</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-8</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Cellular Medicine</gtr:department><gtr:description>Consensus on Epithelial Cells in Idiopathic Pulmonary Fibrosis</gtr:description><gtr:id>8B287D89-F528-4515-B2A4-0007D91DE531</gtr:id><gtr:impact>A consensus statement on the appropriate use of epithelial cells in Idiopathic Pulmonary Fibrosis research was presented at the International Colloquium on Lung Fibrosis in November 2010. The eventual aim of all the participants is to set up a UK-wide consortium for the sharing of knowledge and access to human lung samples.</gtr:impact><gtr:outcomeId>WfmTVTfMx5S-3</gtr:outcomeId><gtr:partnerContribution>Access to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertise</gtr:partnerContribution><gtr:piContribution>Sharing of expert knowledge, and eventually access to human tissue samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Siena</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Goblet cell metaplasia study</gtr:description><gtr:id>11F29A7A-4FA1-4FA1-B89E-87A97856CDC3</gtr:id><gtr:impact>19307611</gtr:impact><gtr:outcomeId>0ADE80C4A1C-2</gtr:outcomeId><gtr:piContribution>Intellectual and technical input, plus provision of research facilities.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>0CB632AA-1093-4595-A555-3D05A1ABFF99</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-14</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Heart &amp; Lung Institute (NHLI)</gtr:department><gtr:description>Consensus on Epithelial Cells in Idiopathic Pulmonary Fibrosis</gtr:description><gtr:id>3A83C881-0F6B-450A-996E-1BDFCAEDE485</gtr:id><gtr:impact>A consensus statement on the appropriate use of epithelial cells in Idiopathic Pulmonary Fibrosis research was presented at the International Colloquium on Lung Fibrosis in November 2010. The eventual aim of all the participants is to set up a UK-wide consortium for the sharing of knowledge and access to human lung samples.</gtr:impact><gtr:outcomeId>WfmTVTfMx5S-2</gtr:outcomeId><gtr:partnerContribution>Access to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertise</gtr:partnerContribution><gtr:piContribution>Sharing of expert knowledge, and eventually access to human tissue samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Gammaherpesvirus infection of lung epithelium</gtr:description><gtr:id>B59DC43B-BBA5-4953-B42D-605A1A1B974E</gtr:id><gtr:impact>A manuscript describing this work is currently under preparation for publication.</gtr:impact><gtr:outcomeId>Ut2Ndi5ybMR-1</gtr:outcomeId><gtr:partnerContribution>Professor Paul Kellam and his team were able to provide use with live Kaposi's Sarcoma Herpesvirus for use in our in vitro studies, plus intellectual input regarding data interpretation.</gtr:partnerContribution><gtr:piContribution>We are investigating the role of gammaherpesvirus infection in the exacerbation of underlying fibrotic lung disease. This work also involves in vitro studies of mechanisms of viral infection in lung epithelium.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:description>Consensus on Epithelial Cells in Idiopathic Pulmonary Fibrosis</gtr:description><gtr:id>30688BE9-CDD6-46CF-BA40-9AA6EA29DCD7</gtr:id><gtr:impact>A consensus statement on the appropriate use of epithelial cells in Idiopathic Pulmonary Fibrosis research was presented at the International Colloquium on Lung Fibrosis in November 2010. The eventual aim of all the participants is to set up a UK-wide consortium for the sharing of knowledge and access to human lung samples.</gtr:impact><gtr:outcomeId>WfmTVTfMx5S-8</gtr:outcomeId><gtr:partnerContribution>Access to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertise</gtr:partnerContribution><gtr:piContribution>Sharing of expert knowledge, and eventually access to human tissue samples</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southern California</gtr:collaboratingOrganisation><gtr:country>Unknown</gtr:country><gtr:department>Keck School of Medicine</gtr:department><gtr:description>Consensus on Epithelial Cells in Idiopathic Pulmonary Fibrosis</gtr:description><gtr:id>4290D4CC-7DFC-4450-BFDA-02D8E7891A2F</gtr:id><gtr:impact>A consensus statement on the appropriate use of epithelial cells in Idiopathic Pulmonary Fibrosis research was presented at the International Colloquium on Lung Fibrosis in November 2010. The eventual aim of all the participants is to set up a UK-wide consortium for the sharing of knowledge and access to human lung samples.</gtr:impact><gtr:outcomeId>WfmTVTfMx5S-4</gtr:outcomeId><gtr:partnerContribution>Access to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertise</gtr:partnerContribution><gtr:piContribution>Sharing of expert knowledge, and eventually access to human tissue samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>99C30BB3-2C4F-4CB5-A090-D69E0E91808B</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-12</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Fibrosis DPU</gtr:department><gtr:description>Micro-CT scanning of experimental lung fibrosis</gtr:description><gtr:id>D6375EBB-1F8F-4440-A050-055A5A6153B5</gtr:id><gtr:impact>This work is now published. PMID: 23520313.
Multi-disciplinary - medical imaging, pathology and experimental medicine</gtr:impact><gtr:outcomeId>hG7jCFzYvyN-1</gtr:outcomeId><gtr:partnerContribution>Provision of access to cutting edge micro-CT scanning technology and analytical software.</gtr:partnerContribution><gtr:piContribution>This work has defined a novel endpoint for analysis of experimental murine lung fibrosis - which is the principal animal model utlised in my CDA. The work should allow more sensitive and reproducible analysis of this animal model, using cutting-edge imaging technology, while reducing the number of animals required.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>5B9D2233-2820-409A-AA79-46CEA14415A2</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-10</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>C260C53C-0F1E-441D-BBCE-D9ECC9A8652F</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-6</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection, Immunity and Inflammation</gtr:department><gtr:description>Consensus on Epithelial Cells in Idiopathic Pulmonary Fibrosis</gtr:description><gtr:id>2E626E19-89E8-42FF-9506-57DBD085E04C</gtr:id><gtr:impact>A consensus statement on the appropriate use of epithelial cells in Idiopathic Pulmonary Fibrosis research was presented at the International Colloquium on Lung Fibrosis in November 2010. The eventual aim of all the participants is to set up a UK-wide consortium for the sharing of knowledge and access to human lung samples.</gtr:impact><gtr:outcomeId>WfmTVTfMx5S-6</gtr:outcomeId><gtr:partnerContribution>Access to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertiseAccess to human tissue samples and/or sharing of expertise</gtr:partnerContribution><gtr:piContribution>Sharing of expert knowledge, and eventually access to human tissue samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Respiratory Biology</gtr:department><gtr:description>Cell therapy for lung fibrosis (HSC-KGF study)</gtr:description><gtr:id>F1B89D86-EAC5-495C-A067-94C9F7A08B51</gtr:id><gtr:impact>19956603</gtr:impact><gtr:outcomeId>5186035A85A-1</gtr:outcomeId><gtr:partnerContribution>Collaboration on the use of lentivirus has provided technical experience for their use in Aim 1 of this MRC fellowship</gtr:partnerContribution><gtr:piContribution>Intellectual and technical input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue Remodeling and Fibrosis Research Consortium</gtr:description><gtr:id>A821AC93-DFE3-46AC-BB42-013B17BEB8FE</gtr:id><gtr:impact>Our original Expression of Interest was successful. The members of the consortium organised a one-day meeting to discuss each other's research and how the consortium will move forward once the various knockout mice become available. A follow-up meeting is in the planning stages.</gtr:impact><gtr:outcomeId>Q36rQ3zWhXs-15</gtr:outcomeId><gtr:partnerContribution>As part of this research consortium, we will have access to a variety of knockout mice as part of the MRC Mouse Network.</gtr:partnerContribution><gtr:piContribution>I am a co-investigator in the Tissue Remodeling and Fibrosis Research Consortium, which is part of the MRC Mouse Network to link in with the International Mouse Phenotyping Consortium. The aims of this consortium are to define the critical regulatory networks underlying the pathogenesis of organ/tissue-based fibrosis and tissue remodelling processes, delineate the cellular and molecular links between tissue injury, subsequent remodeling and the development of fibrosis, and to identify organ-selective and common anti-fibrotic targets. By combining our expertise, we will utilize novel gene knockout mice to discover and develop novel therapies for the treatment of fibrotic diseases, translating our findings into the clinical arena to enhance patient management and treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>In2ScienceUK</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EA58E49B-CF3F-4B24-A503-3D572BEB1B28</gtr:id><gtr:impact>Two A-level students from underpriveleged backgrounds were hosted in our centre for a two-week placement.

Rebecca McKelvey, founder of In2ScienceUK, won the Teach First &amp;quot;Higher Education Access Programme for Schools&amp;quot; Award in 2011, highlighting the impact of this programme.</gtr:impact><gtr:outcomeId>bKKfsfGkbxe</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Charity launch, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FD9171A7-C196-46D6-8962-8BA77BAA7778</gtr:id><gtr:impact>On January 19th 2011, the &amp;quot;Breathing Matters&amp;quot; charitable fund was officially launched. The event was attended by over 120 patients (and family members) who were invited to hear a series of presentations about the Centre for Respiratory Research. I presented research from my CDA in the form of a poster, which required explanation to the lay audience. Subsequently, I attended various Breathing Matters events, aimed at engaging with patients and the public.

Feedback from the patient participants showed that they found it extremely informative, and were grateful for the opportunity to meet with the research and clinical staff in our centre, to discuss what research is being performed.</gtr:impact><gtr:outcomeId>YqfSfpNSFUc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient engagement through Breathing Matters charity</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CF22C237-D31B-4E7C-9E87-9A380E5A3D1C</gtr:id><gtr:impact>This was a fundraising and patient engagement activity, which resulted in additional donations, and positive feedback from patients and their families who had the opportunity to meet the researchers.

Additional charitable donations</gtr:impact><gtr:outcomeId>nCqhnuYh9Qn</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:url>http://www.breathingmatters.co.uk</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Division of Medicine Careers Event</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C75F453B-1532-43F7-BF94-C4CCCFF8B7BD</gtr:id><gtr:impact>Around 30 post-graduate students attended the Division of Medicine Careers Event at UCL, to give them information about the potential careers open to them at the end of their studies. I was asked to talk about a career in Academia.

Unknown.</gtr:impact><gtr:outcomeId>L6kkTAx7qpj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2011,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>61000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Medical School</gtr:department><gtr:description>PhD Studentship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>University of Exeter</gtr:fundingOrg><gtr:id>920F5C6C-E725-4595-A2FC-C1E8561D0672</gtr:id><gtr:outcomeId>5463e40f44e3e2.38785464</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4098</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research grant</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Northcott Devon Medical Foundation</gtr:fundingOrg><gtr:id>88A68EBF-BDD7-455B-AC67-779FAB7B017F</gtr:id><gtr:outcomeId>5463e318216f83.06808695</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>125281</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Industrial CASE Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>E74B395E-5B5C-4700-994B-B4411EE436FE</gtr:id><gtr:outcomeId>Wr2VV6EtzEg0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>37900</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fast Track Grant Application</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>D9693162-5BF6-4832-AC56-1E9ECE88DFDA</gtr:id><gtr:outcomeId>fe79qcxgXgq0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Academy of Medical Sciences Task Force, for 'Increasing engagement with, and providing support to earlier career researchers'</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>924D97BC-D766-4F4D-9D1E-6E1C8F348FFD</gtr:id><gtr:outcomeId>n3g1c9dXsFv</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Epithelial Cells in Idiopathic Pulmonary Fibrosis</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>7A371A78-C3D4-48F2-B00F-2CA13AD32B97</gtr:id><gtr:outcomeId>nxnrwekotPw</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Development of a novel endpoint measure (microCT imaging) for quantification of lung fibrosis in murine models of lung disease, in an effort to improve pre-clinical drug testing and reduce animal use.</gtr:description><gtr:id>F0E4F186-F531-491C-9D85-86D9C6ABA7AD</gtr:id><gtr:impact>In my own research, use of this approach has reduced animal use. The data analysis approach is now being used by a number of research groups, and publications are slowly emerging.</gtr:impact><gtr:outcomeId>56df048c807e34.57826286</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MicroCT analysis of murine lungs</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:url>http://erj.ersjournals.com/content/42/6/1633.long</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>I have contributed expert knowledge to an international consortium that aims to standardise the protocols for isolation and characterisation of primary human lung epithelial cells.</gtr:description><gtr:id>8E6C5D68-FE7E-411F-A340-68CB44AF393C</gtr:id><gtr:impact>A consensus statement regarding the appropriate use of epithelial cells in IPF research was delivered to the International Colloquium on Lung Fibrosis in November 2010.</gtr:impact><gtr:outcomeId>kbDnUEre5Ty</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Standardised isolation of primary human lung epithelium</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Use of micro-CT scanning technology to generate high resolution scans of experimentally-induced murine lung fibrosis, combined with an analytical approach using pattern recognition software, to provide a highly sensitive novel endpoint measure of fibrosis.</gtr:description><gtr:id>7DAA0DC8-78E9-44B8-897B-1BE907D44857</gtr:id><gtr:impact>This approach directly addresses the 3Rs, since it refines the use of our existing animal model of lung fibrosis, and reduces the number of animals required.

This work has been published (PMID: 23520313)</gtr:impact><gtr:outcomeId>N6jmZYFr7Gj</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Micro-CT scanning of experimental lung fibrosis</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Bio-engineering approaches have been used to generate complex cell-scaffold composites, combining mammalian cells with natural or artificial extracellular matrix. These cell-bearing matrices are of use for studying cell-matrix and cell-cell interactions, and also have clear implications for regenerative medicine approaches.</gtr:description><gtr:id>1E0B5484-759B-4EF8-985B-56701CCD16AD</gtr:id><gtr:impact>The proof-of-concept work has been published (PMID: 21755598), and a grant has been submitted to progress the work further.

A follow-up study has recently been published (PMID: 26508202) .</gtr:impact><gtr:outcomeId>s3Du7VKQFms</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cell-bearing matrices</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:url>http://europepmc.org/abstract/MED/21755598</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We developed a three-dimensional in vitro culture system, aimed at better recapitulating a feature (fibrotic foci) of human disease (lung fibrosis) which is not seen in animal models. This in vitro system was then characterized for its potential as a medium-throughput screening tool for pre-clinical drug evaluation.</gtr:description><gtr:id>EA53250B-CD1D-44D7-A36A-330241E853AB</gtr:id><gtr:impact>A publication is due for submission shortly.</gtr:impact><gtr:outcomeId>5463ebc850acb0.37191393</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Three-dimensional in vitro model for pre-clinical drug evaluation in lung fibrosis</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D1754A88-88D0-4FF8-84FC-0F09B1324BD6</gtr:id><gtr:title>Evidence for a functional thymic stromal lymphopoietin signaling axis in fibrotic lung disease.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/388822056cf6618467741207afd24cfe"><gtr:id>388822056cf6618467741207afd24cfe</gtr:id><gtr:otherNames>Datta A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_12492_22_24081992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>663B1D02-BEE5-47D8-A31E-3E94FF591359</gtr:id><gtr:title>Novel therapeutic approaches for pulmonary fibrosis.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/388822056cf6618467741207afd24cfe"><gtr:id>388822056cf6618467741207afd24cfe</gtr:id><gtr:otherNames>Datta A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pu86YiLvxeb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7A96DE9-6D45-4819-AFF3-D8244E3E01B8</gtr:id><gtr:title>Absence of proteinase-activated receptor-1 signaling in mice confers protection from fMLP-induced goblet cell metaplasia.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/895e9c32ff4c3cc738bea475025bf496"><gtr:id>895e9c32ff4c3cc738bea475025bf496</gtr:id><gtr:otherNames>Atzori L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn><gtr:outcomeId>8A900F64C0F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A0424C6-D369-4992-95FC-6835CFCF5CBD</gtr:id><gtr:title>Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8264f3e245676159199c7659b0ef86cb"><gtr:id>8264f3e245676159199c7659b0ef86cb</gtr:id><gtr:otherNames>Mercer PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12492_12_19060230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2453537-215A-4D6E-AAEF-AA9B2A7E7C59</gtr:id><gtr:title>Mechanisms of alveolar epithelial injury, repair, and fibrosis.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81d8e8fced27cb1f73d84688e50dcbb6"><gtr:id>81d8e8fced27cb1f73d84688e50dcbb6</gtr:id><gtr:otherNames>Chambers RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>5a3254a5adcf86.47651349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D8E7BE6-119D-4E1E-97ED-0665CD0D5B2A</gtr:id><gtr:title>Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91b875c1680837c322d2fa0d7b76db63"><gtr:id>91b875c1680837c322d2fa0d7b76db63</gtr:id><gtr:otherNames>Aguilar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5BB5F43E38B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B57A045D-1C37-41CF-93B0-B96839E9847D</gtr:id><gtr:title>Coagulation cascade proteinases in lung injury and fibrosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81d8e8fced27cb1f73d84688e50dcbb6"><gtr:id>81d8e8fced27cb1f73d84688e50dcbb6</gtr:id><gtr:otherNames>Chambers RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1546-3222</gtr:issn><gtr:outcomeId>pm_12492_22_22802281</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B6591ED-FC4B-4CE2-B648-E43B4DEC9E17</gtr:id><gtr:title>Innate immunity in lung fibrosis: a therapeutic role for surfactant protein D?</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5dbdec05cdc4dcc857799257a68863e"><gtr:id>e5dbdec05cdc4dcc857799257a68863e</gtr:id><gtr:otherNames>Scotton CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12492_22_22383565</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>651EACA9-C0C9-4761-B24C-3296BAEDC9C4</gtr:id><gtr:title>Bio-electrosprayed living composite matrix implanted into mouse models.</gtr:title><gtr:parentPublicationTitle>Macromolecular bioscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90e9258d2a98a7176d70598db002ed60"><gtr:id>90e9258d2a98a7176d70598db002ed60</gtr:id><gtr:otherNames>Jayasinghe SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1616-5187</gtr:issn><gtr:outcomeId>VbGuNK71os8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95FEE753-B40F-4D83-AC2D-3EDF1DE3FFBE</gtr:id><gtr:title>Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes.</gtr:title><gtr:parentPublicationTitle>Particle and fibre toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17e455920663019fdd3cf26c8f8fbfdc"><gtr:id>17e455920663019fdd3cf26c8f8fbfdc</gtr:id><gtr:otherNames>Cho WS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1743-8977</gtr:issn><gtr:outcomeId>oigPj311YCt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>653D33F3-B195-4A41-8871-CD2899D8E58B</gtr:id><gtr:title>A breath of fresh air for tissue engineering?</gtr:title><gtr:parentPublicationTitle>Materials Today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/922c0401240eca3bff98213354392fc4"><gtr:id>922c0401240eca3bff98213354392fc4</gtr:id><gtr:otherNames>Scotton C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>HG5jXu61pLU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A01EE899-37E1-4086-B3C2-4C4A833C2210</gtr:id><gtr:title>Platform Technologies for Directly Reconstructing 3D Living Biomaterials.</gtr:title><gtr:parentPublicationTitle>Advanced materials (Deerfield Beach, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90e9258d2a98a7176d70598db002ed60"><gtr:id>90e9258d2a98a7176d70598db002ed60</gtr:id><gtr:otherNames>Jayasinghe SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0935-9648</gtr:issn><gtr:outcomeId>56ba150b4e1d73.70949482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6FE4AD4-B72C-4414-9047-213038040A3B</gtr:id><gtr:title>Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5dbdec05cdc4dcc857799257a68863e"><gtr:id>e5dbdec05cdc4dcc857799257a68863e</gtr:id><gtr:otherNames>Scotton CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>FBCCD0FC34E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBBA5D1C-08F2-4B49-9E0E-5998A48E4891</gtr:id><gtr:title>Bleomycin revisited: towards a more representative model of IPF?</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Lung cellular and molecular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5dbdec05cdc4dcc857799257a68863e"><gtr:id>e5dbdec05cdc4dcc857799257a68863e</gtr:id><gtr:otherNames>Scotton CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1040-0605</gtr:issn><gtr:outcomeId>pm_12492_22_20675435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1AD9566-6328-4F23-920A-5931B63B96FB</gtr:id><gtr:title>Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d4045e5243beb9de8f2709ab4770de0"><gtr:id>8d4045e5243beb9de8f2709ab4770de0</gtr:id><gtr:otherNames>Baliga RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>5463e024e726a7.35380455</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFBD819A-8948-4E9A-A253-A196BB001D62</gtr:id><gtr:title>TGF? upregulates PAR-1 expression and signalling responses in A549 lung adenocarcinoma cells.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16f27d717b6be5cd390d095d6d2585ba"><gtr:id>16f27d717b6be5cd390d095d6d2585ba</gtr:id><gtr:otherNames>Smoktunowicz N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>58c935abb1b9b0.58061005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8147FA6B-D53B-4367-A9E6-CA7549A484E1</gtr:id><gtr:title>The anti-fibrotic effect of inhibition of TGF?-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent ?-herpesvirus infection.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16f27d717b6be5cd390d095d6d2585ba"><gtr:id>16f27d717b6be5cd390d095d6d2585ba</gtr:id><gtr:otherNames>Smoktunowicz N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>56ba150b776577.87176337</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CF51AD6-F5CA-4850-9CAA-4416AD3EF635</gtr:id><gtr:title>In search of the fibrotic epithelial cell: opportunities for a collaborative network.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4adafc2a6d2256275be606b57ffc846"><gtr:id>b4adafc2a6d2256275be606b57ffc846</gtr:id><gtr:otherNames>Jenkins G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_12492_22_21680569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E93076DC-8111-47EE-8A38-B05F5698F64C</gtr:id><gtr:title>Proteinase activated receptor 1 mediated fibrosis in a mouse model of liver injury: a role for bone marrow derived macrophages.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57cc8704e3792ad9d960f7c56d10fd49"><gtr:id>57cc8704e3792ad9d960f7c56d10fd49</gtr:id><gtr:otherNames>Kallis YN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5463e059886e22.35831977</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFEB2750-FA7C-4819-A885-B6DF5A3781F0</gtr:id><gtr:title>Proteinase-activated receptor-1, CCL2, and CCL7 regulate acute neutrophilic lung inflammation.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8264f3e245676159199c7659b0ef86cb"><gtr:id>8264f3e245676159199c7659b0ef86cb</gtr:id><gtr:otherNames>Mercer PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn><gtr:outcomeId>pm_12492_22_23972264</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFDE3C3E-D172-4E6F-BF7F-5430CD426193</gtr:id><gtr:title>Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5dbdec05cdc4dcc857799257a68863e"><gtr:id>e5dbdec05cdc4dcc857799257a68863e</gtr:id><gtr:otherNames>Scotton CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_12492_22_23520313</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800340</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>